Pharmaceutical Industry Fellowships
Mercer University College of Pharmacy has partnered with Azurity Pharmaceuticals and Galt Pharmaceuticals to offer two separate Medical Affairs Fellowships and one Business Development Fellowship in metro Atlanta. Representatives from Mercer, Azurity and Galt traditionally attend ASHP’s Midyear Clinical Meeting and Exhibition and interview applicants through the Personnel Placement Service.
The 2022 Midyear Clinical Meeting and Exhibition will be held Dec. 4 – 8, and representatives from Mercer and Azurity will be attending. If you are not attending, please submit your application to Dr. Lorenzo Villa Zapata at email@example.com. Please specify to which company fellowship you are applying.
Fellows will divide their time between the College and their respective pharmaceutical company, where they will help advance the clinical development of various products and support medical and scientific affairs as products move from development to commercialization. These fellowships are primarily designed to provide the candidate with in-depth experience in medical affairs and will focus on development of skills that will be valuable as graduates transition into a career in the pharmaceutical industry. Fellows will also have the opportunity to work with Mercer faculty on research projects. In addition, they will have opportunity to participate in teaching activities in the College’s Doctor of Pharmacy (Pharm.D.) didactic program.
Applications from candidates in a Pharm.D. degree program or a graduate degree program are sought for the July 2023– June 2024 cycle. Applications must include:
- letter of intent
- curriculum vitae
- an unofficial transcript from graduate/professional degree program (Official transcripts will be required upon acceptance into the fellowship program to confirm degree conferral.)
- letters of recommendation from two references.
All applicants, including those participating in ASHP 2022, must submit materials using this application form by Dec. 3, 2022 for consideration.
Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company that focuses on innovative products that meet the needs of patients with underserved conditions. As an industry leader in providing unique, accessible, and high-quality medications, Azurity leverages its integrated capabilities and vast partner network to continually expand its broad commercial product portfolio and robust late-stage pipeline. The company’s patient-centric products span the cardiovascular, neurology, endocrinology, gastrointestinal, institutional, and orphan markets, and have benefited millions of patients.
- Azurity Medical Affairs Fellowship
The fellow will work primarily within the Azurity Pharmaceuticals’ medical department in Atlanta, led by Evan Scullin, M.D. Fellows will likely be involved in projects ranging from medical information, medical strategy, drug safety investigations and research of new development or in-licensing opportunities.
- Azurity Business Development Fellowship
The fellow will work closely with the business development team in Atlanta, led by Ashley Prange. The fellow will support and drive Azurity’s strategic initiatives, gaining exposure to the full spectrum of activities involved in business development deals.
Galt Pharmaceuticals is a unique pharmaceutical company that seeks to serve unmet needs within health care. The company applies pharmaceutical, managed care and marketing expertise to develop, license and acquire pharmaceutical products for distribution, partnering with independent pharmacies to deliver patient-centered, community-driven care. Galt is the first and only pharmaceutical company to utilize a franchise model, trademarked as “phranchise,” allowing for entrepreneurs the opportunity to build their own pharmaceutical business locally, rather than the centralized, corporate model of traditional pharma.
The fellowship is a one-year experience concentrated in medical affairs, involving various experiences in medical information, scientific communications and field medical support. Fellows also will have the opportunity to be involved in cross-functional projects with regulatory, marketing and commercial operations. In addition, the chosen applicant will work alongside Galt’s two cofounders, CEO Barry Patel, PHARMD ‘92, who co-founded and later sold the pharmaceutical outcomes research and education company Total Therapeutic Management and chairman Wade Smith, PHARMD ‘88, both of whom are Mercer graduates.